
Black Diamond Therapeutics, Inc.
BDTXNasdaqCIK 1701541HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-1617:26 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-061486 |
| 2023-05-0907:45 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001701541-23-000032 |
| 2023-05-0907:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000030 |
| 2023-04-0417:16 ET | DEF 14A | Proxy statementPeriod 2023-05-16 | 0001104659-23-041622 |
| 2023-03-0907:51 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001701541-23-000020 |
| 2023-03-0907:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000018 |
| 2022-12-1908:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-128050 |
| 2022-12-1208:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-126074 |
| 2022-11-0807:12 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001701541-22-000037 |
| 2022-11-0807:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-22-000034 |
| 2022-08-0907:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001701541-22-000029 |
| 2022-08-0907:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-22-000028 |
| 2022-06-0717:14 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-069026 |
| 2022-05-1116:17 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001701541-22-000018 |
| 2022-05-1116:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-22-000017 |
| 2022-04-2816:13 ET | DEF 14A | Proxy statementPeriod 2022-06-07 | 0001104659-22-052245 |
| 2022-04-2509:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-049317 |
| 2022-04-0707:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-043424 |
| 2022-03-1716:38 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001701541-22-000007 |
| 2022-03-1716:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-22-000006 |
| 2022-01-1010:46 ET | 8-K | 8.01 Other events | 0001104659-22-002587 |
| 2022-01-1007:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-002475 |
| 2021-11-2207:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-142198 |
| 2021-11-0807:12 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001701541-21-000039 |
| 2021-11-0807:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-21-000038 |
| 2021-08-1208:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001701541-21-000034 |
| 2021-08-1208:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-21-000032 |
| 2021-08-1016:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-102855 |
| 2021-08-0507:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-100444 |
| 2021-06-2216:12 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-084116 |
| 2021-05-1917:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-069398 |
| 2021-05-0707:19 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001701541-21-000025 |
| 2021-05-0707:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-21-000024 |
| 2021-04-2716:06 ET | DEF 14A | Proxy statementPeriod 2021-06-18 | 0001104659-21-055586 |
| 2021-04-2107:00 ET | 8-K | 5.08 Item not in the standard list | 0001193125-21-123584 |
| 2021-03-2507:15 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001701541-21-000018 |
| 2021-03-2507:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-21-000016 |
| 2021-03-1506:06 ET | 8-K | 8.01 Other events | 0001193125-21-080409 |
| 2021-02-0117:29 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-024781 |
| 2021-01-2007:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-011936 |
| 2020-12-0316:47 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-309605 |
| 2020-11-2317:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-299548 |
| 2020-11-1007:17 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001701541-20-000032 |
| 2020-11-1007:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-20-000031 |
| 2020-09-2908:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-257227 |
| 2020-09-2516:37 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-254645 |
| 2020-08-2116:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-227020 |
| 2020-08-1107:22 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001701541-20-000024 |
| 2020-08-1107:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-20-000023 |
| 2020-05-1207:34 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001701541-20-000018 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.